Toxic epidermal necrolysis (TEN) is an epidermolytic skin disorder associated with drug administration. It is associated with an erythematous rash with full thickness epidermal loss and characteristic histology. A 35-yearold woman underwent allogeneic hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia (SAA). She developed an acute epidermolytic rash and TEN was diagnosed on the basis of skin biopsy. In the HSCT setting, TEN should be thought of as an important differential diagnosis of epidermolytic dermopathies. The most distinctive diagnostic test in the differential diagnosis of these disorders is skin biopsy Bone Marrow Transplantation (2002) 30, 331-333.
Toxic epidermal necrolysis (TEN) counts among the acute epidermolytic dermopathies. The nomenclature of these skin disorders is confusing since various overlapping definitions exist. According to a consensus definition published in 1993, TEN is defined as the most severe type of these kinds of skin reactions with involvement of more than 30% of the body surface area and is differentiated from erythema exsudativum multiforme majus (EEMM) and Stevens Johnson syndrome (SJS). 1 In infants, TEN is sometimes referred to as Ritter's disease (more commonly, however, Ritter's disease is used to describe staphylococcal scalded skin syndrome), whereas in children and adults TEN and Lyell syndrome are used synonymously.
The pathogenesis of TEN is still poorly understood, yet various immunologic and non-immunologic mechanisms are presumed to play an important role such as druginduced hypersensitivity, cell mediated immune keratinocyte apoptosis, abnormal drug metabolism, cumulative toxicity or metabolic disturbances. 2, 3 Drugs that have been purported to induce TEN include sulfonamides, tetracyclines, carbamazepine, allopurinol, barbiturates, bromides, hydantoins, antimalarial agents, gold, cancer chemotherapeutic agents, coumarin or nonsteroidal anti-inflammatory agents. 2, 4 TEN is suggested by widespread full thickness epidermal loss (clinically as positive Nikolsky sign, blistering or 'wet tissue paper') leaving denuded areas and characteristic histological findings demonstrating a cleavage plane which is located between the epidermis and dermis or at the level of the basal cell. 5 Involvement of mucosal surfaces is frequently found. TEN has an acute onset, occurring 1 to 3 weeks after drug ingestion. 4, 6 Suspected drugs should be withdrawn immediately. The prognosis is poor with a mortality rate of more than 40%, 1 despite appropriate therapy including isolation and burn unit placement, early treatment of infections and supportive care, such as high caloric intake and correction of electrolyte imbalance. According to most authors, systemic steroids should be avoided, yet their role is still controversial. 3, 5, [7] [8] [9] Death is caused by multiorgan sequelae due to infection and fluid and electrolyte disturbances subsequent to the loss of the protective skin barrier.
Case report
We report a 35-year-old woman who underwent allogeneic hematopoietic stem cell transplantation (HSCT) for severe aplastic anemia (SAA) which she had probably developed in relation to neuroleptic drug intake. She was admitted to our center 4 weeks after she was diagnosed and had already been treated for pneumonia and perianal abscesses. Blood count on admission was: WBC 0.6 ϫ 10 9 /l, Hb 7.3 g/dl, platelets 22 ϫ 10 9 /l. The preparative regimen consisted of ATG 30 mg/kg i.v. once daily for 4 consecutive days and cyclophosphamide 50 mg/kg i.v. once daily for 4 consecutive days, followed by an allogeneic matched related donor (MRD) peripheral blood stem cell transplant (PBSCT) (4.11 ϫ 10 6 CD34 + cells/kg). GVHD prophylaxis included cyclosporin A (CsA) starting on day Ϫ2 with 5 mg/kg once daily i.v., short course methotrexate (15 mg/m 2 i.v. on day +1, 10 mg/m 2 i.v. on days +3 and +6) and prednisolone starting on day +7 with 0.5 mg/kg once daily i.v. Pneumocystis carinii prophylaxis consisted of trimethoprime/sulfamethoxazole 160 mg/800 mg p.o. twice daily from day Ϫ7 to day Ϫ2. As uric acid prophylaxis she received allopurinol 300 mg p.o. once daily from day Ϫ5 to day Ϫ2. No drug sensitivities were documented during this period.
From day Ϫ4, the WBC was on average 0.15 ϫ 10 9 /l. On day +3 she started to develop a generalized erythema with bullous epidermolysis and a positive Nikolsky sign covering more than 50% of the body surface area ( Figure  1) . Mucosal surfaces however, were not involved. TEN was suspected on clinical grounds and the corresponding supportive treatment was initiated. The CRP jumped from 9.6 mg/dl to 31.5 mg/dl on day +3 and increased further to 56.9 mg/dl on day +12. Bacteriological tests revealed coagulase negative staphylococci in the throat, trachea, vagina and intestine. Several anti-infective regimens comprising ceftazidim, tobramycin, talcoplanin, imipenem, clindamycin, levofloxacin, amikacin, amphothericin B and aciclovir did not bring about an improvement. From day +7 hemodialysis was instituted due to acute renal failure, with elevation of creatinine (3.5 mg/dl) and urea (171 mg/dl), and she required ventilation because of respiratory failure. Tachyarrhythmia occurred on day +13 causing clinical deterioration and death ensued from multiple system organ failure.
Autopsy revealed a hypoplastic marrow consistent with non-engraftment, an acellular fibrinous exsudative pneumonia and histological findings consistent with TEN. Discussion TEN is a rare, but life-threatening skin disorder. In the HSCT setting it is a fatal complication on which only few cases have been reported in the literature to date. 10, 11 The skin reaction in this patient was probably induced by immunologically mediated reactions against either sulfamethoxazole or allopurinol which were part of the pretransplant preparative regimen between day Ϫ7 and Ϫ2. In Figure 1 Toxic epidermal necrolysis: typical macroscopic findings. Toxic epidermal necrolysis after allogeneic HSCT for SAA: erythema, blistering and full-thickness epidermal loss is seen over the trunk and upper arm. In total, over 50% of the body surface area was affected.
addition, skin lesions as seen in this case could possibly be due to chemotherapy-related toxicity, such as in patients with a DNA repair defect.
This patient showed a number of clinical findings and factors that have been ascribed to a bad prognosis in TEN: ingestion of many drugs, neutropenia, lymphopenia, thrombocytopenia, elevation of urea and creatinine and widespread necrolysis. 12 It is noteworthy that she developed TEN despite having been commenced on CsA which has been reported to be beneficial in this condition, 5 days prior to its onset. On the other hand, the GVHD prophylaxis also included prednisolone from day +7 which might have an unfavorable effect in TEN. However, although controversial, systemic corticosteroids have been administered in TEN with the idea of possibly stopping further immunologic damage to the skin. Systemic steroids are reported to have been used successfully when initiated at earlier stages of the disease, 9 but have been shown to be deleterious in advanced cases. 9 The role of steroids, intravenous immunoglobulins and various immunosuppressive agents including cyclophosphamide, cyclosporin A, pentoxifyllin and thalidomide remains to be established by controlled studies. 9, 13 Apart from TEN, the differential diagnosis of HSCTassociated acute epidermal necrolysis includes, among others, viral exanthema, staphylococcal scalded skin syndrome (SSSS), epidermolysis bullosa, bullous fixed drug eruptions, erythema multiforme, listeriosis, syphilis, methotrexate-induced skin necrosis or severe cutaneous GVHD. 6, 10 The major differential diagnoses in our patient were GVHD and SSSS. GVHD could be ruled out because engraftment had not yet occurred. SSSS is caused by exfoliative toxins (ET) of S. aureus and almost always occurs in infants or children Ͻ6 years of age. 6 Coagulase negative staphylococci -as found in our patient -do not produce these toxins. SSSS can be differentiated histologically from TEN, since in SSSS the cleavage plane is not situated below but within the epidermis. 5 Skin and blister fluid are usually sterile in SSSS since the skin lesions are caused by ET excreted by S. aureus, but the skin itself is not infected (in contrast to bullous impetigo). However, in TEN patients the skin may be colonized by S. aureus, since secondary bacterial skin infections are found frequently here. 6 In SSSS, systemic penicillinase-resistant anti-staphylococcal antibiotics must be started as soon as the clinical diagnosis is made. Corticosteroids are contraindicated. 6 In the HSCT setting, TEN should be considered important in the differential diagnosis of epidermolytic dermopathies. It is crucial to differentiate TEN early from other skin disorders, such as SSSS or GVHD, since therapy is different. 4, 6, 9 Examination of the patient by an experienced dermatologist will often help in reaching the diagnosis promptly, and will also help in choosing an appropriate area to biopsy. Even if skin biopsy cannot always distinguish between TEN and its differential diagnoses, it is still the most sensitive and specific diagnostic test in the differential diagnosis of these disorders.
